Why the Facility of the Year Awards are Important to Pharma Industry
ISPE’s Facility of the Year Awards (FOYA) program recognizes the shared commitment and dedication of companies worldwide, to enhance patient health and safety through innovation and advancement.
“The FOYA Award is important [to the] industry as a whole because it provides a platform to share knowledge and experience,” said Ryan Hawkins, Vice President and Chief Operating Officer, Cook Pharmica, LLC, 2017 FOYA Category Winner for Equipment Innovation.
“If you think about it, where else can you get that type of snapshot of major projects, of major technological advances in [the] industry, [and it] also says a lot about the importance of the FOYA awards,” said Hawkins.
Christopher Sweeney, Senior General Manager, Pt Kalbio Global Medika, 2017 FOYA Honorable Mention shared, “The reason why we joined the FOYA awards was that we’re very proud of our facility and we wanted to show the industry that in Indonesia, we can build the equivalent, or even better of some of the facilities in the West.”
The Facility of the Year Awards category winners represent the epitome of companies who utilize pioneering technology and design to help set the standard for future pharmaceutical facilities.
“We really felt that [it] was a vindication of our design and our hard work, and it gave confidence to the parent company to expand our operations,” said Sweeney.
“Being a winner of the FOYA award, and being worthy of that distinction, means a lot,” said Hawkins. “What it means, is we’re becoming operational, and with the purpose of serving more customers and therefore more patients.”
The 2017 FOYA Facility of the Future and Overall Winner was awarded to Eli Lilly and Company. “[We] appreciate ISPE for leading the industry towards where we want to go,” said David Sternasty, Vice President of Corporate Engineering and Global Health, Safety and Environment.
Through the ISPE Foundation Professional Development Grant program, Silas Tamufor attended the 2023 ISPE Annual Meeting & Expo in October 2023. Tamufor is a PhD student and ISPE Boston Chapter member who began serving as the ISPE Boston Educational Programs Committee Chair in December 2023. He, along with 87 other students and recent graduates, attended the conference thanks to the...
To meet the biopharmaceutical industry’s duty to manufacture safe and effective therapies for patients, a robust quality system is fundamental to success. A quality system should link to quality culture and prioritize focusing on quality, led by management, that fosters sustainable compliance and consistent production of high-quality drugs. Strong quality culture attributes include a proactive...
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...